Methods for treating cancers using polymorphic forms of 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2 -yl)-piperidine-2,6-dione

Details for Australian Patent Application No. 2010200373 (hide)

Owner Celgene Corporation

Inventors Zeldis, Jerome B.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2010200373

Parent 2004240548

Filing date 2 February 2010

Wipo publication date 18 February 2010

Acceptance publication date 7 June 2012

International Classifications

A61K 31/00 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/454 (2006.01)

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

18 February 2010 Application Open to Public Inspection

  Published as AU-B-2010200373

18 February 2010 Complete Application Filed

7 June 2012 Application Accepted

  Published as AU-B-2010200373

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010200374-Suture management system for surgical portal apparatus including numbered clips

2010200372-Tubular Support Prosthesis with Laterally Overlapping Arcs of Curvature